Form 8-K - Current report:
SEC Accession No. 0001628280-25-000958
Filing Date
2025-01-08
Accepted
2025-01-08 16:45:34
Documents
13
Period of Report
2025-01-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K jush-20250106.htm   iXBRL 8-K 23535
  Complete submission text file 0001628280-25-000958.txt   141629

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jush-20250106.xsd EX-101.SCH 1770
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jush-20250106_lab.xml EX-101.LAB 20974
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jush-20250106_pre.xml EX-101.PRE 12037
15 EXTRACTED XBRL INSTANCE DOCUMENT jush-20250106_htm.xml XML 2630
Mailing Address 301 YAMATO ROAD SUITE 3250 BOCA RATON FL 33431
Business Address 301 YAMATO ROAD SUITE 3250 BOCA RATON FL 33431 5616179100
Jushi Holdings Inc. (Filer) CIK: 0001909747 (see all company filings)

EIN.: 981547061 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56468 | Film No.: 25519062
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)